Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia

Ni Qiu1, Zhousheng Xiao, Li Cao

  • 1Department of Medicine, the University of Tennessee Health Science Center, Memphis, TN 38165, USA.

Journal of Cell Science
|February 24, 2012
PubMed

Insights

Kinesin family member 3A (Kif3a) in osteoblasts is crucial for bone formation. Deleting Kif3a in these cells impairs primary cilia, leading to osteopenia and altered bone cell function.

Area of Science:

  • Cell Biology
  • Bone Biology
  • Genetics

Background:

  • Kinesin family member 3A (Kif3a) is essential for intracellular transport.
  • The role of Kif3a in osteoblasts and its direct impact on bone formation are not fully understood.
  • Primary cilia are increasingly recognized for their roles in skeletal development and homeostasis.

Purpose of the Study:

  • To investigate the direct role of Kif3a in osteoblasts in regulating postnatal bone formation.
  • To determine the impact of Kif3a deletion in osteoblasts on primary cilia structure and function.
  • To elucidate the molecular mechanisms by which Kif3a deficiency affects osteoblast activity and bone mass.

Main Methods:

  • Conditional deletion of Kif3a in osteoblasts using osteocalcin (Oc)-Cre and Kif3a(flox/null) mice.
  • Analysis of Kif3a transcript levels, primary cilia number and length in osteoblasts.
  • Assessment of bone mineral density, trabecular bone volume, and cortical thickness in Kif3a conditional knockout mice.
  • Evaluation of osteoblast function in vivo (mineral apposition rate) and in vitro (proliferation, differentiation, adipogenesis).
  • Measurement of intracellular calcium levels and responses to fluid shear stress.
  • Analysis of hedgehog and Wnt signaling pathway components (Gli2, β-catenin, Axin2).

Main Results:

  • Conditional deletion of Kif3a in osteoblasts led to a significant reduction in Kif3a transcripts and impaired primary cilia.
  • Kif3a conditional knockout mice exhibited osteopenia, characterized by reduced bone mineral density, trabecular bone volume, and cortical thickness.
  • Loss of Kif3a in osteoblasts resulted in impaired osteoblast function, decreased mineral apposition rate, and altered expression of key bone formation markers (Runx2, Osterix, Osteocalcin, Dmp1).
  • In vitro studies showed increased proliferation, impaired differentiation, and enhanced adipogenesis in Kif3a-deficient osteoblasts.
  • Kif3a deficiency led to reduced basal and fluid flow-stimulated intracellular calcium levels.
  • Hedgehog and Wnt signaling pathways were attenuated in Kif3a-deficient osteoblasts.

Conclusions:

  • Selective deletion of Kif3a in osteoblasts disrupts primary cilia formation and/or function.
  • Kif3a is essential for osteoblast-mediated bone formation.
  • Impaired bone formation in Kif3a-deficient osteoblasts is mediated by dysregulation of intracellular calcium, hedgehog, and Wnt signaling pathways.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview